Astec Lifesciences Ltd

₹ 1,054 0.16%

22 Nov 9:47 a.m.

About

The Company is into manufacturing of agrochemical active ingredients (technical), bulk and formulations, intermediate products and it sells its products in India as well as exports them to approximately 24 countries.
Astec also has undertaken a number of custom synthesis projects, for its clients in Europe, Japan and the US. It is present only in business to business sale (B2B).^[1] ^[2] ^[3]

Key Points

Product Portfolio
The company offers a range of products and intermediates, including fungicides, insecticides, herbicides, and various chemical compounds, serving global customers and including triazole fungicides, heterocyclic herbicides, sulfonylurea herbicides, synthetic pyrethroids, fluorinated compounds, halides, intermediates, ketones, ethers, alcohols, and many others. ^[1]

Website BSE NSE

Market Cap ₹ 2,067 Cr.
Current Price ₹ 1,054
High / Low ₹ 1,488 / 825
Stock P/E
Book Value ₹ 148
Dividend Yield 0.00 %
ROCE -4.50 %
ROE -11.9 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Cons

Stock is trading at 7.08 times its book value
Company has low interest coverage ratio.
The company has delivered a poor sales growth of 1.24% over past five years.
Company has a low return on equity of 5.97% over last 3 years.
Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian

Part of BSE Allcap BSE Commodities BSE SmallCap

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	103	173	272	184	200	117	127	143	111	51	154	69	99
	81	130	207	159	166	105	122	140	114	69	141	116	118
Operating Profit	21	43	65	25	33	12	5	3	-3	-18	13	-46	-20
OPM %	21%	25%	24%	14%	17%	10%	4%	2%	-3%	-36%	8%	-67%	-20%
	1	2	7	3	4	4	3	2	1	1	2	1	2
Interest	2	3	3	4	5	6	6	6	6	6	7	7	9
Depreciation	8	9	11	9	8	9	8	9	9	9	9	9	11
Profit before tax	12	33	58	15	25	1	-6	-11	-18	-32	-1	-62	-39
Tax %	25%	25%	26%	26%	25%	31%	-19%	-26%	-24%	-24%	3%	-36%	0%
	9	25	43	11	18	1	-5	-8	-13	-24	-1	-40	-39
EPS in Rs	4.63	12.63	21.96	5.81	9.33	0.42	-2.55	-4.19	-6.86	-12.42	-0.50	-20.26	-19.67
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
	165	189	252	221	298	368	431	522	555	677	628	458	372
	138	155	200	190	236	299	354	437	443	522	551	464	444
Operating Profit	27	34	52	31	63	69	76	85	112	154	77	-6	-72
OPM %	16%	18%	21%	14%	21%	19%	18%	16%	20%	23%	12%	-1%	-19%
	0	0	-15	-0	-8	12	11	12	8	10	13	5	6
Interest	7	9	12	12	12	11	12	13	5	9	21	25	29
Depreciation	12	14	12	10	14	15	19	23	26	34	34	36	39
Profit before tax	9	11	12	8	29	56	56	61	89	121	35	-62	-133
Tax %	32%	22%	-18%	95%	33%	37%	36%	23%	27%	26%	27%	-24%
	6	9	15	0	19	35	36	47	65	90	26	-47	-104
EPS in Rs	3.29	4.65	7.59	0.18	9.78	17.91	18.25	24.26	33.03	45.83	13.02	-23.96	-52.85
Dividend Payout %	23%	22%	16%	0%	15%	8%	8%	6%	5%	3%	12%	-6%

Compounded Sales Growth
10 Years:	9%
5 Years:	1%
3 Years:	-6%
TTM:	-25%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	-301%

Stock Price CAGR
10 Years:	26%
5 Years:	22%
3 Years:	-8%
1 Year:	-16%

Return on Equity
10 Years:	13%
5 Years:	11%
3 Years:	6%
Last Year:	-12%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	18	19	19	19	20	20	20	20	20	20	20	20	20
Reserves	89	96	117	99	118	150	183	227	289	376	399	349	271
	70	79	93	127	127	125	176	99	188	280	341	494	501
	81	85	128	84	69	119	83	227	182	221	219	111	90
Total Liabilities	258	279	358	329	334	413	461	572	678	897	979	974	881
	120	130	127	94	103	115	167	194	213	340	318	386	539
CWIP	13	6	12	20	8	42	19	24	116	23	127	165	2
Investments	1	1	1	0	0	0	0	0	0	0	0	0	0
	124	142	217	214	223	256	275	354	349	534	533	423	340
Total Assets	258	279	358	329	334	413	461	572	678	897	979	974	881

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	15	14	3	3	19	65	15	169	-8	23	74	10
	-13	-16	-14	-16	-18	-49	-52	-74	-73	-104	-112	-135
	-1	2	11	15	-1	-18	37	-95	81	80	38	125
Net Cash Flow	1	-0	-0	2	1	-2	-0	0	0	0	-0	0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	133	86	143	132	136	122	103	112	123	148	90	135
Inventory Days	133	187	143	186	133	122	121	131	113	176	268	224
Days Payable	137	120	181	179	117	156	83	219	137	180	161	102
Cash Conversion Cycle	129	153	105	140	152	88	141	24	99	145	197	256
Working Capital Days	126	135	122	150	155	115	147	77	101	163	175	234
ROCE %	9%	11%	20%	10%	20%	22%	20%	20%	22%	22%	8%	-4%

Shareholding Pattern

Numbers in percentages

	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	65.19%	65.29%	65.29%	66.77%	66.76%	66.76%	66.76%	66.75%	66.75%	66.75%	66.75%	66.74%
	0.29%	0.32%	0.48%	1.53%	2.19%	2.29%	1.95%	1.33%	1.28%	1.25%	1.03%	0.53%
	12.74%	12.56%	11.79%	9.82%	9.57%	10.58%	10.15%	10.16%	9.74%	7.88%	3.37%	4.50%
	21.78%	21.83%	22.45%	21.87%	21.49%	20.37%	21.13%	21.74%	22.22%	24.12%	28.85%	28.20%
No. of Shareholders	19,002	16,951	17,433	17,632	19,545	17,809	18,703	18,722	19,244	19,848	19,955	19,727

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
	65.54%	67.31%	67.62%	71.33%	65.23%	65.29%	66.76%	66.75%	66.74%
	1.87%	0.77%	0.89%	0.84%	0.25%	0.32%	2.29%	1.25%	0.53%
	0.27%	2.17%	2.10%	0.51%	10.67%	12.56%	10.58%	7.88%	4.50%
	0.00%	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	32.32%	29.74%	29.39%	27.32%	23.85%	21.83%	20.37%	24.12%	28.20%
No. of Shareholders	11,907	13,197	12,771	10,701	19,872	16,951	17,809	19,848	19,727

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

DRHP

Credit ratings

Concalls

Nov 2022
Transcript
PPT
Nov 2022
Transcript
PPT
May 2022
Transcript
PPT
Nov 2021
Transcript
PPT
Aug 2021
Transcript
PPT
Feb 2021
Transcript
PPT